Novadip is transforming the lives of patients using its unique 3M3 tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip´s mission is to provide innovative solutions for patients with limited or no effective treatment options.
Find locations served, office locations
- Business Type:
- Industry Type:
- Medical Research
- Market Focus:
- Nationally (across the country)
- Year Founded:
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
At 45 and counting
Our growing team is experienced in all aspects of research, development and manufacturing of innovative therapies and dedicated to delivering life-changing solutions to patients with high unmet needs.
(basic science, in vivo preclinical & clinical results) in peer-review journals with 265 citations.
15 procedures for bone reconstruction
(6 tumor reconstruction, 5 bone non-union, 4 spine surgery) and 7 implantions for skin regeneration utilizing early versions of technology.